An Introduction to Airway and Lung Infection
The field of airway and lung infection is topical in the wake of the COVID-19 pandemic; SARS-CoV-2 is one of several novel respiratory viruses to emerge in the 21st century. Viruses and bacteria can cause a range of respiratory diseases, including acute bronchitis, the common cold, influenza, respiratory distress syndromes, pertussis, pneumonia and tuberculosis. Symptoms of viral infections may range from being very mild to a severe respiratory illness, and therefore prompt and reliable diagnosis is essential. Antibiotic resistance remains the major challenge in bacterial infection. Emerging approaches include cell-based therapies involving mesenchymal stem cells in the treatment of respiratory infections. However, the multiple challenges involved in developing curative therapies for infections highlight the importance of prevention, and vaccine research is essential.
Browse our selection of video highlights and short articles from the conference hub, providing insights into the latest updates from major conferences and a selection of peer-reviewed articles from the journal portfolio.
Our supporting partners do not constitute an endorsement of the content on this page.
Respiratory Infections Content
The mRNA vaccine platform: A novel tool for the rapid development of vaccines against respiratory viral infections
Leading experts explore mRNA vaccine platforms for respiratory viruses, including their design, clinical application and future prospects.
- Recognize the rationale for mRNA-based vaccines and considerations for their design
- Discuss the effectiveness of mRNA-based vaccines to manage respiratory viral diseases based on clinical and real-world experiences with COVID-19 vaccines
- Discuss recent developments in the use of the mRNA platform to develop prophylactic and therapeutic vaccines for respiratory diseases
Contemporary insights on the management of sickle cell disease: Focus on complications and recent advances in therapy
Three experts discuss the management of complications of sickle cell disease, as well as recent advances in therapy.
- Summarize the various manifestations and multiple complications of SCD
- Appraise the practical considerations for the multidisciplinary management of SCD complications
- Interpret the clinical data for established and recently approved therapies for SCD and apply them to clinical practice
Uniting to end the TB epidemic: World TB Day 2023
World Tuberculosis (TB) Day is observed annually on 24 March to raise awareness about tuberculosis and to commemorate the discovery of the Mycobacterium tuberculosis bacterium (M.tb) by Dr Robert Koch in 1882. It aims to educate people about the impact of TB on public health, and encourage governments and organizations to take action towards ending the TB […]
Improving the alpha-mannosidosis patient journey
An expert gives her perspectives on the history and prevalence of alpha-mannosidosis, its diagnosis and treatment options
- Describe the prevalence and natural history of the rare lysosomal storage disorder alpha-mannosidosis (AM)
- Explain how diagnosis of AM may be approached, and describe the methods of disease identification
- Outline current and emerging management and treatment options for patients with AM
Management of patients with NTM-LD: Improving adherence for optimal outcomes
Watch expert pulmonologists discuss how to optimize the diagnosis and management of patients with NTM-LD
- Appraise strategies to reduce time to diagnosis for patients with NTM-LD
- Utilize guideline recommendations when setting individualized treatment goals for patients with NTM-LD
- Apply strategies to manage adverse events for improved outcomes and adherence in patients with NTM-LD
Francesca Conradie, World Conference on Lung Health 2022: A delamanid-bedaquiline regimen for rifampicin-resistant tuberculosis- findings from BEAT tuberculosis
BEAT tuberculosis (NCT04062201) investigated treatment with a short course of a delamanid-bedaquiline regimen for rifampicin resistant tuberculosis (RR-TB) in South Africa. It was a pleasure to talk with Dr Francesca Conradie (University of the Witwatersrand, Johannesburg, South Africa) around the aims and design of the BEAT tuberculosis study and the findings from the interim analysis. […]
Véronique Suttels, World Conference on Lung Health 2022: Point-of-care ultrasound as a potential triage tool for tuberculosis (Part 2)
Point-of-care ultrasound (POCUS) is a potential triage tool for tuberculosis (TB) that could allow non-specialist healthcare workers to guide decision-making in TB management. In this touchRESPIRATORY interview, we speak with Dr. Veronique Suttels (Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland) to discuss the intermediate analysis of the study investigating POCUS in Benin and the potential impact […]
Véronique Suttels, World Conference on Lung Health 2022: Point-of-care ultrasound as a potential triage tool for tuberculosis (Part 1)
Pulmonary tuberculosis (TB) is a contagious infectious disease caused by Mycobacterium tuberculosis, symptoms can include a cough, chest pain and breathlessness, and in some cases the infection can spread to other organs. In this touchRESPIRATORY interview, we speak with Dr. Veronique Suttels (Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland) to discuss the strengths and limitations of […]
The patient pathway to diagnosis for non-cystic fibrosis bronchiectasis
MDT specialists and a patient with non-cystic fibrosis (non-CF) bronchiectasis discuss the pathophysiology, comorbidities and the pathway to diagnosis
- Describe the pathophysiology and comorbidities of non-CF bronchiectasis
- Appraise the clinical presentations of non-CF bronchiectasis
- Analyse the methodologies to diagnose non-CF bronchiectasis